Our solution takes you from single cell or single-nuclei suspension through library prep and sequencing and delivers immediate results via our analysis software, Trailmaker.
Our solution takes you from single cell or single-nuclei suspension through library prep and sequencing and delivers immediate results via our analysis software, Trailmaker.
Bukowski K, Kciuk M, Kontek R. Mechanisms of Multidrug Resistance in Cancer Chemotherapy. International Journal of Molecular Sciences. 2020; 21(9):3233. https://doi.org/10.3390/ijms21093233
Chang, X., Zheng, Y. & Xu, K. Single-Cell RNA Sequencing: Technological Progress and Biomedical Application in Cancer Research. Mol Biotechnol 66, 1497–1519 (2024). https://doi.org/10.1007/s12033-023-00777-0
Cheng, B., Yu, Q. & Wang, W. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra. J Biomed Sci 30, 1 (2023). https://doi.org/10.1186/s12929-022-00894-z
Dong C, Wu J, Chen Y, et al. Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer. Front Pharmacol. 2021;12:628690. Published 2021 Mar 15. https://doi.org/10.3389/fphar.2021.628690
Haughton, P.D., Haakma, W., Chalkiadakis, T. et al. Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer. Oncogene 43, 2463–2474 (2024). https://doi.org/10.1038/s41388-024-03091-4
Hernández Borrero, L. J., & El-Deiry, W. S. (2021). Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochimica et biophysica acta. Reviews on cancer, 1876(1), 188556. https://doi.org/10.1016/j.bbcan.2021.188556
Hu, A., Sun, L., Lin, H. et al. Harnessing innate immune pathways for therapeutic advancement in cancer. Sig Transduct Target Ther 9, 68 (2024). https://doi.org/10.1038/s41392-024-01765-9
Huang Z, Wu T, Liu AY, Ouyang G. Differentiation and transdifferentiation potentials of cancer stem cells. Oncotarget. 2015;6(37):39550-39563. https://doi.org/10.18632/oncotarget.6098
Huang, L., Guo, Z., Wang, F. et al. KRAS mutation: from undruggable to druggable in cancer. Sig Transduct Target Ther 6, 386 (2021). https://doi.org/10.1038/s41392-021-00780-4
Kalpana Ravi, Yining Zhang, Lydia Sakala, et al. Tumor Microenvironment On-A-Chip and Single-Cell Analysis Reveal Synergistic Stromal–Immune Crosstalk on Breast Cancer Progression. Advanced Science (2025) https://doi.org/10.1002/advs.202413457
Laplane, L., Maley, C.C. The evolutionary theory of cancer: challenges and potential solutions. Nat Rev Cancer 24, 718–733 (2024). https://doi.org/10.1038/s41568-024-00734-2
Li, Y., Lim, C., Dismuke, T. et al. Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179. Nat Commun 16, 1091 (2025). https://doi.org/10.1038/s41467-024-54861-3
Ling He, Daria Azizad, Kruttika Bhat, Angeliki Ioannidis, et al. Radiation-Induced Cellular Plasticity: A Strategy for Combatting Glioblastoma bioRxiv 2024.05.13.593985; https://doi.org/10.1101/2024.05.13.593985
Lintz, M., Muñoz, A., & Reinhart-King, C. A. (2017). The Mechanics of Single Cell and Collective Migration of Tumor Cells. Journal of biomechanical engineering, 139(2), 0210051–0210059. https://doi.org/10.1115/1.4035121
Park, S. R., Namkoong, S., Friesen, L., Cho, C. S., Zhang, Z. Z., Chen, Y. C., Yoon, E., Kim, C. H., Kwak, H., Kang, H. M., & Lee, J. H. (2020). Single-Cell Transcriptome Analysis of Colon Cancer Cell Response to 5-Fluorouracil-Induced DNA Damage. Cell reports, 32(8), 108077. https://doi.org/10.1016/j.celrep.2020.108077
Patwardhan MV, Kane TQ, Chiong E, Rahmat JN, Mahendran R. Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer. International Journal of Molecular Sciences. 2024; 25(24):13296. https://doi.org/10.3390/ijms252413296
Perini, G.F., Ribeiro, G.N., Pinto Neto, J.V. et al. BCL-2 as therapeutic target for hematological malignancies. J Hematol Oncol 11, 65 (2018). https://doi.org/10.1186/s13045-018-0608-2
Pfeffer, C. M., & Singh, A. T. K. (2018). Apoptosis: A Target for Anticancer Therapy. International journal of molecular sciences, 19(2), 448. https://doi.org/10.3390/ijms19020448
Quail, D., Joyce, J. Microenvironmental regulation of tumor progression and metastasis. Nat Med 19, 1423–1437 (2013). https://doi.org/10.1038/nm.3394
Ratha Mahendran; Mugdha Vijay Patwardhan; Qin Kane Toh; Edmund Chiong Abstract B051: GSTT2 modulates the bladder tumor environment and response to BCG Immunotherapy Cancer Immunol Res (2023) 11 (12_Supplement): B051. https://doi.org/10.1158/2326-6074.TUMIMM23-B051
Saldana-Guerrero, I.M., Montano-Gutierrez, L.F., Boswell, K. et al. A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations. Nat Commun 15, 3745 (2024). https://doi.org/10.1038/s41467-024-47945-7
Shiau, C., Cao, J., Gong, D. et al. Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment. Nat Genet 56, 2466–2478 (2024). https://doi.org/10.1038/s41588-024-01890-9
Song, P., Gao, Z., Bao, Y. et al. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol 17, 46 (2024). https://doi.org/10.1186/s13045-024-01563-4
Spasevska, I., Sharma, A., Steen, C. B., et al. (2023). Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma. Blood advances, 7(23), 7216–7230. https://doi.org/10.1182/bloodadvances.2023010158
Su S, Li X. Dive into Single, Seek Out Multiple: Probing Cancer Metastases via Single-Cell Sequencing and Imaging Techniques. Cancers. 2021; 13(5):1067. https://doi.org/10.3390/cancers13051067
Tufail, M., Jiang, CH. & Li, N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Sig Transduct Target Ther 10, 227 (2025). https://doi.org/10.1038/s41392-025-02280-1
Wei, X., Chen, Y., Jiang, X., et al. (2021). Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Molecular cancer, 20(1), 7. https://doi.org/10.1186/s12943-020-01288-1
Ye, Ying-Hui et al. Identification of tumor heterogeneity associated with KRAS/TP53 co-mutation status in lung adenocarcinoma based on single-cell RNA sequencing. American journal of cancer research vol. 14,2 655-678. 15 Feb. 2024, https://doi.org/10.62347/NXAJ9418
Yuning J. Tang, Haiqing Xu, Nicholas W. Hughes et al. Functional mapping of epigenetic regulators uncovers coordinated tumor suppression by the HBO1 and MLL1 complexes bioRxiv 2024.08.19.607671; https://doi.org/10.1101/2024.08.19.607671
Zhan, Q., Liu, B., Situ, X. et al. New insights into the correlations between circulating tumor cells and target organ metastasis. Sig Transduct Target Ther 8, 465 (2023). https://doi.org/10.1038/s41392-023-01725-9
Zhou J, Tien AC, Alberta JA, et al. A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2. Cell Rep. 2017;18(13):3167-3177. https://doi.org/10.1016/j.celrep.2017.03.003
Li, Q., Li, Z., Luo, T. et al. Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy. Mol Biomed 3, 47 (2022). https://doi.org/10.1186/s43556-022-00110-2
Koyama S, Nishikawa H. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies. Journal for ImmunoTherapy of Cancer. 2021;9:e002591. https://doi.org/10.1136/jitc-2021-002591
